In the News - Updated January 3, 2016

USNWI continues to grow!

In our ongoing efforts to provide quality, ‘close to home’ urologic care to our patients, old and new, USNWI is continuing to grow to meet this need. Dr. Adam Perlmutter, a well established fellowship trained local Urologist is joining our staff and will provide care in Merrillville, Munster and Plymouth. Dr. Emley has joined the consulting staff of Francisian Health Rensselaer and will provide outpatient services on a weekly basis.


Dutasteride (Avodart) and Finasteride (Proscar)

There has been a recent warning issued on these drugs that they increase the risk of prostate cancer.  Both are commonly used medications for benign prostatic hypertrophy (BPH, a common condition amongst men.  Both are effective when treating BPH and improve symptoms, reduce prostatic bleeding and decrease the risk of needing surgery for BPH.  They are often used in combination with tamulosin (Flomax) and other drugs in that class and this dual therapy works better than monotherapy.

When these drugs were first used they were actually studied as a medication to reduce the risk of prostate cancer.  What has become clear from the data generated from these studies is that they do reduce the risk of prostate cancer.  However they reduce the risk of developing what we call a low grade or low risk prostate cancer.  These cancers are often slow growing and not clinically significant.  Use of these drugs resulted in an overall decrease in prostate cancer risk of 26%, but had a 1.3% increase in the risk of developing a high grade prostate cancer.  In other words, if 200 men took these drugs, then 1 would develop a high grade prostate cancer that would not have if he had not taken the drug.

Both dutasteride and finasteride are effective at treating BPH symptoms.  There is, however a very small risk of developing a high grade cancer due to the medication.  The decision to take these drugs depends on your particular situation and symptoms and should be fully discussed with your physician prior to starting or continuing treatment.